中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/08/08 | 5,900 | 6,118 | 5,823 | 5,967 | -205 | -3.3% | 2,832,200 |
2024/08/07 | 5,866 | 6,443 | 5,853 | 6,172 | +125 | +2.1% | 4,158,100 |
2024/08/06 | 6,140 | 6,287 | 5,866 | 6,047 | +107 | +1.8% | 4,596,900 |
2024/08/05 | 6,235 | 6,366 | 5,853 | 5,940 | -460 | -7.2% | 4,613,300 |
2024/08/02 | 6,370 | 6,548 | 6,345 | 6,400 | -80 | -1.2% | 3,146,300 |
2024/08/01 | 6,409 | 6,557 | 6,364 | 6,480 | -129 | -2% | 2,224,400 |
2024/07/31 | 6,549 | 6,611 | 6,408 | 6,609 | +59 | +0.9% | 2,841,200 |
2024/07/30 | 6,439 | 6,563 | 6,357 | 6,550 | +211 | +3.3% | 2,587,600 |
2024/07/29 | 6,210 | 6,437 | 6,205 | 6,339 | +75 | +1.2% | 2,089,300 |
2024/07/26 | 6,326 | 6,402 | 6,191 | 6,264 | +238 | +3.9% | 3,551,800 |
2024/07/25 | 6,100 | 6,198 | 5,980 | 6,026 | -136 | -2.2% | 2,855,200 |
2024/07/24 | 5,986 | 6,214 | 5,970 | 6,162 | +151 | +2.5% | 2,122,800 |
2024/07/23 | 5,915 | 6,048 | 5,915 | 6,011 | +82 | +1.4% | 1,079,400 |
2024/07/22 | 5,929 | 6,000 | 5,893 | 5,929 | +29 | +0.5% | 1,943,200 |
2024/07/19 | 5,897 | 5,942 | 5,806 | 5,900 | -83 | -1.4% | 2,575,600 |
2024/07/18 | 5,959 | 6,035 | 5,856 | 5,983 | -76 | -1.3% | 2,986,900 |
2024/07/17 | 6,120 | 6,128 | 6,033 | 6,059 | -5 | -0.1% | 2,731,600 |
2024/07/16 | 6,219 | 6,230 | 6,058 | 6,064 | -220 | -3.5% | 2,668,900 |
2024/07/12 | 6,254 | 6,371 | 6,226 | 6,284 | -70 | -1.1% | 4,467,200 |
2024/07/11 | 6,412 | 6,429 | 6,321 | 6,354 | -41 | -0.6% | 2,624,200 |
2024/07/10 | 6,286 | 6,425 | 6,257 | 6,395 | +108 | +1.7% | 2,698,600 |
2024/07/09 | 6,153 | 6,323 | 6,098 | 6,287 | +94 | +1.5% | 2,462,100 |
2024/07/08 | 6,181 | 6,359 | 6,162 | 6,193 | -7 | -0.1% | 3,155,700 |
2024/07/05 | 6,127 | 6,211 | 6,122 | 6,200 | +100 | +1.6% | 2,170,700 |
2024/07/04 | 6,047 | 6,129 | 5,984 | 6,100 | +117 | +2% | 3,713,800 |
2024/07/03 | 5,850 | 6,023 | 5,836 | 5,983 | +197 | +3.4% | 3,123,600 |
2024/07/02 | 5,644 | 5,830 | 5,625 | 5,786 | +138 | +2.4% | 2,607,100 |
2024/07/01 | 5,600 | 5,685 | 5,548 | 5,648 | -68 | -1.2% | 2,732,000 |
2024/06/28 | 5,846 | 5,849 | 5,671 | 5,716 | -83 | -1.4% | 3,559,400 |
2024/06/27 | 5,772 | 5,839 | 5,750 | 5,799 | -13 | -0.2% | 2,874,200 |
2024/06/26 | 5,693 | 5,819 | 5,653 | 5,812 | +175 | +3.1% | 4,690,700 |
2024/06/25 | 5,438 | 5,637 | 5,420 | 5,637 | +279 | +5.2% | 3,875,900 |
2024/06/24 | 5,200 | 5,359 | 5,191 | 5,358 | +201 | +3.9% | 3,263,600 |
2024/06/21 | 5,100 | 5,167 | 5,087 | 5,157 | +15 | +0.3% | 2,537,000 |
2024/06/20 | 5,132 | 5,192 | 5,064 | 5,142 | -11 | -0.2% | 1,703,100 |
2024/06/19 | 5,106 | 5,162 | 5,050 | 5,153 | +104 | +2.1% | 2,556,200 |
2024/06/18 | 4,950 | 5,049 | 4,943 | 5,049 | +107 | +2.2% | 1,888,200 |
2024/06/17 | 4,960 | 4,969 | 4,867 | 4,942 | -11 | -0.2% | 2,047,000 |
2024/06/14 | 4,986 | 5,017 | 4,876 | 4,953 | -42 | -0.8% | 3,875,500 |
2024/06/13 | 5,036 | 5,037 | 4,931 | 4,995 | +29 | +0.6% | 1,900,200 |
2024/06/12 | 4,940 | 4,974 | 4,913 | 4,966 | -12 | -0.2% | 2,459,900 |
2024/06/11 | 4,811 | 4,978 | 4,811 | 4,978 | +167 | +3.5% | 2,137,800 |
2024/06/10 | 4,761 | 4,845 | 4,756 | 4,811 | +54 | +1.1% | 1,117,700 |
2024/06/07 | 4,777 | 4,802 | 4,715 | 4,757 | -55 | -1.1% | 1,670,800 |
2024/06/06 | 4,862 | 4,865 | 4,798 | 4,812 | -2 | ±0% | 1,536,700 |
2024/06/05 | 4,807 | 4,814 | 4,725 | 4,814 | +27 | +0.6% | 1,357,100 |
2024/06/04 | 4,742 | 4,802 | 4,700 | 4,787 | -25 | -0.5% | 1,888,600 |
2024/06/03 | 4,850 | 4,872 | 4,812 | 4,812 | +31 | +0.6% | 1,415,700 |
2024/05/31 | 4,714 | 4,816 | 4,693 | 4,781 | +89 | +1.9% | 6,295,300 |
2024/05/30 | 4,640 | 4,705 | 4,572 | 4,692 | +8 | +0.2% | 2,310,000 |
201~
250
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム